Coronary Artery Disease Clinical Trial
Official title:
Multi-modality Imaging in Acute Myocardial Infarction
The goal of this study is to use three (3) different imaging techniques:Fractional Flow Reserve (FFR) allows precise measurement of blood flow in the arteries to the heart, and is more reliable than pictures alone to determine the significance of blockages in the heart; Near Infra-Red Spectroscopy-Intravascular Ultrasound (NIRS IVUS) provides information about the amount of lipid and cholesterol in the plaque, and plaque volume; and Optical Coherence Tomography (OCT) allows physicians to assess tears in the surface of plaque and plaque thickness; to evaluate high risk non-infarct-related coronary lesion in patients who have suffered a recent heart attack, underwent successful opening of the artery with a stent, and have blockages greater than or equal to 50% in one or more of the other arteries to the heart; and to correlate this findings with cardiovascular outcomes at 1 year.
This is a prospective, open-label, single center registry. The study is designed to
characterize plaque (i.e., assess vulnerable plaque features such as plaque tears, plaque
thickness, plaque volume, and lipid content in plaque) in heart arteries in patients who have
suffered a recent acute heart attack, and who have blockages >50% in one or more of the other
arteries in the heart. The procedure to do this will not be the same procedure that was done
to open the artery that caused the heart attack, but will be scheduled 2-40 days after the
first procedure, depending on the urgency to evaluate the other arteries and the stability of
the patient after the first procedure. The study will specifically evaluate the plaque
characteristics in the arteries that didn't cause the heart attack, to see if these arteries
have vulnerable plaque and is at risk for future heart attacks. If FFR shows abnormal blood
flow, these arteries will be treated with stents. All patients will be followed for 12 months
after the second catheterization. The purpose of the study is to determine how commonly
vulnerable plaques are identified in patients with acute heart attacks, and how often these
lead to future cardiac problems. Identification of plaque features that lead to future
problems may allow the development of new medications and devices to prevent future heart
attacks and death. These same plaque features are also thought to be operative in patients
with blockages in the arteries to the brain, so this study may have important implications
for stroke prevention as well. All patients will be considered eligible for participation if
they had a recent acute heart attack resulting from complete occlusion of an artery to the
heart, if the stent procedure to open the artery was successful, and if they have blockages >
50% in at least one other major heart artery. Patients will not be eligible for participation
if they are too unstable with regard to heart, lung, brain, or kidney function, or if they
have previous bypasses to the heart.
In selected patients, Coronary CT Angiography (CCTA) will be performed after the initial
procedure to open the artery within 40 days. CCTA images will be evaluated for plaque
characteristics, and correlated with the invasive findings.Fractional flow reserve via
computed tomography (FFRCT), a non-invasive computed tomography method of measuring blood
flow in the blocked arteries; will also be determined and correlated with invasive FFR.
The standard portion of the procedure includes the angiogram (X-ray pictures of the
arteries), FFR (measurement of blood flow in the artery), IVUS and/or OCT (to assess the
diameter of the artery and the size of the stent), medications, and all office visits. The
research portion of the study requires all imaging studies be performed (NIRS IVUS, OCT, FFR)
rather than just one or two of these imaging studies, and the CCTA.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |